Amgen Inc. is expected to file its next quarterly report (Form 10-Q), for the period ending about Sept. 30, 2026, between Nov. 2, 2026 and Nov. 9, 2026, based on its last 8 10-Q filings. The SEC deadline for a large accelerated filer is Nov. 9, 2026.
How the next-report window is calculated
Amgen Inc.'s most recent periodic report on file is a Form 10-Q for the period ended June 30, 2026, filed Aug. 5, 2026. Its fiscal year ends around Dec. 31, so the next period should close about Sept. 30, 2026, and that report is a Form 10-Q.
SEC rules give a large accelerated filer 40 days after period end to file a 10-Q, which lands on Nov. 9, 2026 after moving off weekends and federal holidays. Over its last 8 10-Qs, Amgen Inc. filed between 31 and 38 days after period end (median 35 days), which gives the expected window above. Period ends are estimated from the company's own calendar and may shift by a few days in 52/53-week fiscal years.
Recent filings by Amgen Inc.
| Filed | Form | What it is | Document |
|---|---|---|---|
| 10-Q | Quarterly report with unaudited financial statements for the period ended June 30, 2026 | Open 10-Q filed 2026-08-05 · Index 0000318154-26-000126 | |
| 8-K | Released earnings or financial results | Open 8-K filed 2026-08-04 · Index 0000318154-26-000124 | |
| 8-K | Material cybersecurity incident | Open 8-K filed 2026-07-31 · Index 0000318154-26-000119 | |
| 11-K | Annual report of an employee stock purchase or savings plan | Open 11-K filed 2026-06-11 · Index 0000318154-26-000114 | |
| 11-K | Annual report of an employee stock purchase or savings plan | Open 11-K filed 2026-06-11 · Index 0000318154-26-000113 | |
| 8-K | Reported shareholder vote results | Open 8-K filed 2026-05-20 · Index 0001193125-26-232786 | |
| 8-K | Executive or board change, or executive pay arrangement | Open 8-K filed 2026-05-19 · Index 0000318154-26-000097 | |
| 13G | Ownership above 5% by a passive or institutional investor | Open SCHEDULE 13G filed 2026-05-14 · Index 0001422849-26-000085 | |
| 10-Q | Quarterly report with unaudited financial statements for the period ended March 31, 2026 | Open 10-Q filed 2026-05-01 · Index 0000318154-26-000057 | |
| 8-K | Released earnings or financial results | Open 8-K filed 2026-04-30 · Index 0000318154-26-000054 | |
| 13G | Ownership above 5% by a passive or institutional investor | Open SCHEDULE 13G filed 2026-04-29 · Index 0002100119-26-000132 | |
| 8-K | Executive or board change, or executive pay arrangement | Open 8-K filed 2026-04-22 · Index 0000318154-26-000048 | |
| DEFA14A | Additional proxy soliciting materials | Open DEFA14A filed 2026-04-21 · Index 0000318154-26-000045 | |
| DEFA14A | Additional proxy soliciting materials | Open DEFA14A filed 2026-04-15 · Index 0000318154-26-000040 | |
| DEFA14A | Additional proxy soliciting materials | Open DEFA14A filed 2026-04-07 · Index 0001193125-26-145596 | |
| DEF 14A | Definitive proxy statement for a shareholder meeting | Open DEF 14A filed 2026-04-07 · Index 0001193125-26-145588 | |
| ARS | Annual report delivered to shareholders | Open ARS filed 2026-03-31 · Index 0000318154-26-000035 | |
| 13G/A | Amendment to a passive-ownership (13G) report | Open SCHEDULE 13G/A filed 2026-03-26 · Index 0000102909-26-000625 | |
| 25-NSE | Exchange notice removing a security from listing | Open 25-NSE filed 2026-02-24 · Index 0001354457-26-000212 | |
| 8-K | Signed a material contract | Open 8-K filed 2026-02-19 · Index 0001193125-26-059490 | |
| S-3ASR | Automatic shelf registration (well-known seasoned issuer) | Open S-3ASR filed 2026-02-13 · Index 0001193125-26-051627 | |
| 10-K | Annual report with audited financial statements for the period ended Dec. 31, 2025 | Open 10-K filed 2026-02-13 · Index 0000318154-26-000010 | |
| 8-K | Released earnings or financial results | Open 8-K filed 2026-02-03 · Index 0000318154-26-000003 | |
| 8-K | Ended a material contract | Open 8-K filed 2026-01-30 · Index 0001193125-26-030518 | |
| 10-Q | Quarterly report with unaudited financial statements for the period ended Sept. 30, 2025 | Open 10-Q filed 2025-11-05 · Index 0000318154-25-000072 |
What Amgen Inc.'s 8-Ks were about in the past year
Amgen Inc. filed 10 Form 8-K current reports between Oct. 17, 2025 and Oct. 16, 2026. Each report lists the item numbers it covers; the counts below show how often each item appeared.
| Item | Meaning | Times |
|---|---|---|
| 9.01 | Financial Statements and Exhibits | 7 |
| 2.02 | Results of Operations and Financial Condition | 4 |
| 5.02 | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 2 |
| 1.05 | Material Cybersecurity Incidents | 1 |
| 5.07 | Submission of Matters to a Vote of Security Holders | 1 |
| 1.01 | Entry into a Material Definitive Agreement | 1 |
| 1.02 | Termination of a Material Definitive Agreement | 1 |